Showing results (661-670 of 1,276) with videos related to
Sort By:
Pageof 128
JACC. Cardiovascular Interventions|January 21, 2017
First-in-Human Evaluation of a Novel Polymer-Free Drug-Filled Stent: Angiographic, IVUS, OCT, and Clinical Outcomes From the RevElution StudyStephen G Worthley, Alexandre Abizaid, Ajay J Kirtane, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 28, 2010
Sirolimus versus paclitaxel coronary stents in clinical practiceNiklas Millauer, Peter Jüni, Alexandra Hofmann, et al.Lancet (London, England)|October 28, 2023
Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trialJuan F Iglesias, Marco Roffi, Sylvain Losdat, et al.Journal of the American Heart Association|November 24, 2021
Effect of Timing of Staged Percutaneous Coronary Intervention on Clinical Outcomes in Patients With Acute Coronary SyndromesTatsuhiko Otsuka, Sarah Bär, Sylvain Losdat, et al.JACC. Cardiovascular Interventions|May 7, 2021
Validation of the 2019 Expert Consensus Algorithm for the Management of Conduction Disturbances After TAVRDaniel Malebranche, Joanna Bartkowiak, Christoph Ryffel, et al.Heart Rhythm|August 19, 2021
Permanent pacemaker implantation late after transcatheter aortic valve implantationElena Elchinova, Nikolas Nozica, Joanna Bartkowiak, et al.Journal of Thrombosis and Haemostasis : JTH|January 30, 2025
The individual fibrinolytic capacity predicts the efficacy of ultrasound-assisted catheter-directed thrombolysis in patients with acute pulmonary embolismDominik F Draxler, Justine Brodard, Heidi Ho, et al.The Canadian Journal of Cardiology|February 13, 2022
Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary InterventionCarlo Andrea Pivato, Davis Jones, Davide Cao, et al.Journal of the American Heart Association|November 11, 2017
Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary SyndromesBaris Gencer, Konstantinos C Koskinas, Lorenz Räber, et al.Preventive Medicine Reports|January 3, 2022
Association between self-reported motivation to quit smoking with effectiveness of smoking cessation intervention among patients hospitalized for acute coronary syndromes in SwitzerlandInge Worni-Schudel, Vasilis Tzalis, Julian Jakob, et al.Pageof 128